financetom
Business
financetom
/
Business
/
NYSE Chicago to reincorporate in Texas
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NYSE Chicago to reincorporate in Texas
Feb 12, 2025 5:54 AM

Feb 12 (Reuters) - The New York Stock Exchange's

division in Chicago will be reincorporated in Texas, the company

said in a statement on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Citigroup nearly shifted $6 billion to wealth account, Bloomberg reports
Citigroup nearly shifted $6 billion to wealth account, Bloomberg reports
Mar 3, 2025
March 3 (Reuters) - Citigroup ( C/PN ) almost shifted about $6 billion to a customer's account by accident after a staffer handling the transfer copied and pasted the account number into a field for the dollar figure, Bloomberg News reported on Monday, citing people familiar with the matter. ...
Amneal, mAbxience's Biologics Licensing Application for Denosumab Biosimilars Accepted for Review by FDA
Amneal, mAbxience's Biologics Licensing Application for Denosumab Biosimilars Accepted for Review by FDA
Mar 3, 2025
05:33 PM EST, 03/03/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) and Fresenius Kabi's mAbxience unit said Monday that the US Food and Drug Administration accepted for review their biologics licensing application for two proposed denosumab biosimilars. Denosumab is a monoclonal antibody that inhibits bone resorption and is used to treat conditions such as osteoporosis and bone metastases from...
Corcept Therapeutics Says New Drug Application for Cushing's Syndrome Treatment Filed by FDA
Corcept Therapeutics Says New Drug Application for Cushing's Syndrome Treatment Filed by FDA
Mar 3, 2025
05:29 PM EST, 03/03/2025 (MT Newswires) -- Corcept Therapeutics ( CORT ) said its new drug application for relacorilant to treat endogenous hypercortisolism, or Cushing's syndrome, was filed by the US Food and Drug Administration. The application is based on the results of trials showing positive results, the company said Monday in a statement. The FDA aims to complete its...
Green Dot Names Kim Olson Chief Risk Officer
Green Dot Names Kim Olson Chief Risk Officer
Mar 3, 2025
05:31 PM EST, 03/03/2025 (MT Newswires) -- Green Dot ( GDOT ) said Monday it appointed Kim Olson as chief risk officer. Olson will oversee the company's risk management strategy and program execution while reporting directly to the chief executive. Most recently, Olson was head of the office of remediation at Discover Financial Services ( DFS ) , Green Dot...
Copyright 2023-2026 - www.financetom.com All Rights Reserved